Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Mesothelioma, Malignant 2Mesothelioma 2

Interventions

pembrolizumab 12Pemetrexed 9Cisplatin 9Nivolumab 8Carboplatin 8Ipilimumab 7Cyclophosphamide 6fludarabine 5durvalumab 4tremelimumab 2Radiotherapy, Intensity-Modulated 2Gemcitabine 2Cerebral Decortication 2tocilizumab 1tislelizumab 1tazemetostat 1sotorasib 1ruxolitinib 1osimertinib 1olaparib 1obinutuzumab 1naptumomab estafenatox 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1bintrafusp alfa protein, human 1avelumab 1atezolizumab 1Tumor Burden 1Temozolomide 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma × Cerebral Decortication × 1 year × Clear all
NCT04158141 2026-05-19

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

NRG Oncology

Phase 3 Terminated
16 enrolled 18 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00715611 2026-05-14

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
65 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡